| Title： | Expert consensus on the immune checkpoint inhibitors treatment for recurrent/metastatic head and neck squamous cell carcinoma |
| Edition： | Original |
| Classification： | Experts consensus |
| Field： | Treatment |
| Countries and regions： | China |
| Guidelines users： | Chinese oncologists |
| Evidence classification method： | Oxford Centre for Evidence-Based Medicine |
| Development unit： | Head and Neck Cancer Committee of Chinese Society of Clinical Oncology |
| Registration time: | 2023-04-19 |
| Registration number： | PREPARE-2023CN273 |
| Purpose of the guideline: | To guide the immunotherapy of reccurent/metastatic head and neck squamous cell carcinoma in China |
